09:58 AM EST - Theratechnologies Inc. : has been informed by Ferrer Internacional S.A. (Ferrer), its commercial partner responsible for all regulatory filings in Europe, that it is withdrawing the Marketing Authorization Application (MAA) filed with the European Medicines Agency (EMA) for tesamorelin for the treatment of excess abdominal fat in HIV-infected patients with lipodystrophy. Theratechnologies Inc.
shares T.TH are trading down $1.03 at $0.87.
